Quick Answer
aTYR PHARMA INC reported Stockholders Equity of $67.48 million for the year ending 2025.
- aTYR PHARMA INC showed a decrease of -3.6% in Stockholders Equity from 2024 to 2025.
- This data is from aTYR PHARMA INC's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$98.01 million | Q2 2015: $139.34 million | Q3 2015: $129.16 million | Q1 2016: $100.43 million | Q2 2016: $86.57 million | Q3 2016: $73.99 million | Q1 2017: $50.71 million | Q2 2017: $40.03 million | Q3 2017: $72.29 million | Q1 2018: $54.50 million | Q2 2018: $45.38 million | Q3 2018: $38.99 million | Q1 2019: $29.49 million | Q2 2019: $30.23 million | Q3 2019: $26.74 million | Q1 2020: $42.13 million | Q2 2020: $36.10 million | Q3 2020: $32.16 million | Q1 2021: $49.70 million | Q2 2021: $40.98 million | Q3 2021: $117.61 million | Q1 2022: $98.55 million | Q2 2022: $86.64 million | Q3 2022: $77.18 million | Q1 2023: $109.88 million | Q2 2023: $106.24 million | Q3 2023: $98.39 million | Q1 2024: $84.47 million | Q2 2024: $81.61 million | Q3 2024: $65.33 million | Q1 2025: $75.05 million | Q2 2025: $74.85 million | Q3 2025: $80.24 million.
- Over the full 14 years of available data (2012 to 2025), aTYR PHARMA INC's Stockholders Equity has grown by 204.5%.
- Historical annual values: Fiscal year 2025: $67.48 million | Fiscal year 2024: $70.02 million | Fiscal year 2023: $90.66 million | Fiscal year 2022: $71.46 million | Fiscal year 2021: $109.30 million | Fiscal year 2020: $31.65 million | Fiscal year 2019: $21.19 million | Fiscal year 2018: $33.65 million | Fiscal year 2017: $64.25 million | Fiscal year 2016: $62.80 million | Fiscal year 2015: $115.05 million | Fiscal year 2014: -$91.01 million | Fiscal year 2013: -$66.08 million | Fiscal year 2012: -$64.55 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: